Twitter Beğeni Hilesi

Just out in JAMA: Long-term outcomes of prostate cancer AS in PASS. Since 2008: ➡️2,155 patients with median 7.2 year f/u. ➡️21 patients have developed metastatic disease ➡️3 prostate cancer-related deaths jamanetwork.com/journals/jama/… Track each patient 👇

🔥🔥 Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage - Nguyen - Histopathology - Wiley Online Library onlinelibrary.wiley.com/doi/10.1111/hi…

Grateful to Helen Burstin, MD (@helenburstinmd on IG & 🧵) Moore Foundation National Academy of Medicine for elevating this important topic & driving us all to define opportunities to improve care (+ 🙌 to 🤩🤩 Logan Galansky for leading this)

The IBCG Quick Guide to Non-Muscle Invasive Bladder Cancer (NMIBC) Bladder Cancer Quick Reference Sheet summarizes essential details on diagnosis, treatment options, and follow-up for NMIBC all in one convenient place #AUA24 #EAU24 #IBCG24 #ASCO24 Designed by Amanda Myers

Curious where the next prostate cancer screening rec will land

Listen to the whole clip 💔 x.com/KNBR/status/18…

Till I’m blue in the face, if we want histologic grading to accurately reflect oncologic reality, rename pattern 3 and every biopsy/RP quantifies amount of pattern 4 (and 5).

Meticulous methods, exhaustive data wrangling, systematic elimination of alternative explanations. a tour de force of research that quantifies what most health policy folks have long believed hospital price increases (eg through market power) hurts people, employers, communities

Excited to share our manuscript addressing a novel linkage between the Decipher genomic classifier and real-world clinical data with >92,000 patients securely linked jamanetwork.com/journals/jaman… Chris Filson Tyler Seibert MD PhD Decipher by Veracyte Elai Davicioni Matt Cooperberg

Grateful to collaborate with Chris Filson Elai Davicioni Tyler Seibert MD PhD Daniel E Spratt Matt Cooperberg @ ashley ross @ preston sprenkle Yale Urology Decipher by Veracyte

x.com/carokell/statu…

ICYMI: This paper from Jane K Nguyen MD PhD and Jesse McKenney on rethinking Gleason grading is a really big deal. Splitting all patterns into "favorable" and "unfavorable" amounts to the best biomarker I think I've ever seen for #prostatecancer.

every time I’m ready to give up on the giants’ season they pull me back in

The second pioneering fellow of Emory Uro Onc. Welcome William!

As good as I've seen. Should be mandatory reading for all PCP's and urologists who screen for PrCa Prostate-specific antigen screening for prostate cancer: Diagnostic pe... sciencedirect.com/science/articl… Michael Leapman Preston Sprenkle, MD

Viewpoint discusses the importance of hormone deprivation–free survival as an end point for both men with prostate cancer and women with breast cancer. ja.ma/3SjUut2

On this first day of #ProstateCancerAwarenessMonth, let's remember the importance of early detection. Survival rates for early stage disease are incredibly strong. Get screened! American Cancer Society